Defense Conferences / Aerospace & Defense Market

National Security Matters

COVID-19

Ology Bioservices, Vanderbilt University Medical Center to Develop, Manufacture Monoconal Antibody for Treatment, Prevention of Infection With COVID-19 Virus for Department of Defense

By

The Department of Defense (DOD) awarded a contract valued at $14 million with Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), to develop and manufacture a monoclonal antibody for treatment and prevention of infection with the COVID-19 virus. This work is supported by the Office of the Assistant Secretary of Defense for Health … [Read more...] about Ology Bioservices, Vanderbilt University Medical Center to Develop, Manufacture Monoconal Antibody for Treatment, Prevention of Infection With COVID-19 Virus for Department of Defense

Coronavirus Pandemic Solutions Sought by Government

By

At the direction of the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), the Medical CBRN Defense Consortium (MCDC) has released a Request for Information (RFI) seeking solutions to combat the novel Coronavirus (2019-NCoV) pandemic with a focus on the following areas: 1) Diagnostics/Monitoring, 2) Surveillance, 3) … [Read more...] about Coronavirus Pandemic Solutions Sought by Government

De Nora Supports Italian Civil Protection Agencies in the Fight Against the Coronavirus – COVID-19 Pandemic

By

Industrie De Nora S.p.a. (De Nora), is supporting the efforts of the Civil Protection Department by deploying four electrochlorination systems in northern Italy, near Milan. The electrochlorination systems produce sodium hypochlorite, a chlorine equivalent that is suitable for the disinfection of hard surfaces and, according to the World Health Organization (WHO), is effective … [Read more...] about De Nora Supports Italian Civil Protection Agencies in the Fight Against the Coronavirus – COVID-19 Pandemic

Coronavirus (COVID-19) Update: FDA Issues New Policy to Help Expedite Availability of Diagnostics

By

Today, as part of the U.S. Food and Drug Administration's ongoing and aggressive commitment to address the coronavirus outbreak, the agency issued a new policy for certain laboratories seeking to develop diagnostic tests for coronavirus in order to achieve more rapid testing capacity in the U.S. "We believe this policy strikes the right balance during this public health … [Read more...] about Coronavirus (COVID-19) Update: FDA Issues New Policy to Help Expedite Availability of Diagnostics